Monday, January 23, 2012
Repeat business? FDA approves new cancer drug to treat toxicity caused by another cancer drug
U.S. health regulators gave the nod on Tuesday to a drug from British specialty drugmaker BTG Plc that helps cancer patients get rid of toxic levels of a chemotherapy treatment. The drug, called Voraxaze, helps eliminate methotrexate in patients whose kidney function has been compromised by treatment with high doses of the chemotherapy agent. Methotrexate is normally eliminated from the body by the kidneys, but prolonged high doses of the drug used to treat cancer can result in kidney failure.
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment